Post-effective amendment to a registration statement that is not immediately effective upon filing

Share based compensation - Summary of stock option activity (Details)

v3.22.1
Share based compensation - Summary of stock option activity (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Jul. 27, 2021
Dec. 31, 2021
Dec. 31, 2020
Number of shares      
Outstanding at the beginning   2,414,303  
Exercised (1,833,596) (516,025)  
Outstanding at the end     2,414,303
Options vested and exercisable   1,004,883  
Weighted average exercise price      
Outstanding at the beginning (in dollars per share)   $ 2.17  
Outstanding at the end (in dollars per share)     $ 2.17
Options vested and exercisable   $ 2.25  
Weighted average remaining remaining term (in years)      
Outstanding     8 years 2 months 12 days
Options vested and exercisable   6 years 2 months 12 days  
Aggregate intrinsic value      
Outstanding at the beginning (in dollars)   $ 53,660  
Outstanding at the end (in dollars)     $ 53,660
Options vested and exercisable   $ 3,056  
2016 Omnibus Inventive Plan [Member]      
Number of shares      
Granted   892,224  
Forfeited   (390,187)  
Exercised   (516,025)  
Outstanding at the end   2,400,315  
Weighted average exercise price      
Granted (in dollars per share)   $ 13.95  
Forfeited (in dollars per share)   (3.73)  
Exercised (in dollars per share)   (2.23)  
Outstanding at the end (in dollars per share)   $ 6.28  
Weighted average remaining remaining term (in years)      
Outstanding   7 years 9 months 18 days  
Granted (in years)   9 years 10 months 24 days  
Aggregate intrinsic value      
Granted (in dollars)   $ 3,825  
Forfeited   (7,562)  
Exercised (in dollars)   (3,645)  
Outstanding at the end (in dollars)   $ 4,224  
As previously reported      
Number of shares      
Outstanding at the beginning (as previously reported)     486,755
Weighted average exercise price      
Outstanding at the beginning (as previously reported)     $ 10.79
Weighted average remaining remaining term (in years)      
Outstanding at the beginning (as previously reported) (in years)     8 years 9 months 18 days
Aggregate intrinsic value      
Outstanding at the beginning (as previously reported) (in dollars)     $ 19,572
Retroactive application of reverse recapitalization      
Number of shares      
Retroactive application of reverse recapitalization     1,927,548
Weighted average exercise price      
Retroactive application of reverse recapitalization     $ (8.62)